Founded in 2002, Aurigene is a clinical-stage biotech company dedicated to discovering and developing novel therapeutics for cancer treatment. Leveraging its deep expertise in oncology, Aurigene aims to benefit cancer patients worldwide.

Aurigene has supported Doctors for Seva (DFS) by funding the AHAP project across the country for the past year, empowering nearly 3,000 students through their contributions.